companies antares-pharma-inc 
Benzinga
APRIL 13, 2022
Antares Pharma Inc (NASDAQ: ATRS ) shares are trading higher Wednesday after the company announced it will be acquired by Halozyme Therapeutics Inc (NASDAQ: HALO ) for $5.60 per share in cash, valuing Antares at approximately $960 million. The transaction was unanimously approved by both.
Benzinga
APRIL 13, 2022
Halozyme Buys Specialty Product Company Antares In $960M Deal. Halozyme Therapeutics Inc (NASDAQ: HALO ) will acquire Antares Pharma Inc (NASDAQ: ATRS ) for $5.60 per share , valuing Antares at approximately $960 million. Stocks In Focus. ATRS shares are surging 48.1% during the premarket session.
Expert insights. Personalized for you.
98 
Let's personalize your content